NCT06390163Completed
Effects of Sensory-Motor Integration Training in Patients with Idiopathic Parkinson's Disease
Investigation the Effects of Sensory-Motor Integration Training on Cognitive Functions, Balance and Gait in Patients with Idiopathic Parkinson's Disease
Source: ClinicalTrials.gov · Last updated 27 Dec 2024
Brief summary (registry, in English)
The goal of this single blind randomized controlled trial is to investigate the effect of sensory-motor integration training on cognitive functions, balance and gait in patients with Parkinson Disease? The main questions it aims to answer are: * Does sensory-motor integration training have an effect on balance in patients with Parkinson Disease? * Does sensory-motor integration training have an effect on cognitive functions in patients with Parkinson Disease? * Does sensory-motor integration training have an effect on gait in patients with Parkinson Disease? Patients in the control group will be asked to continue their routine lives and return for evaluation after 8 weeks. Individuals in the control group will be followed without any additional treatment or advice. Patients in the study group will receivesensory-motor integration training for 60 minutes, 3 days a week for 8 weeks, in addition to their routine lives. No additional recommendations will be given to individuals in either group.
- Status (registry)
- Completed
- Study type
- Interventional
- Enrollment
- 40 (actual)
- First submitted
- 1 Mar 2024
- Start date
- 5 May 2024
- Primary completion date
- 20 Oct 2024
- Lead sponsor
- Hacettepe University
- Diseases
- Parkinson disease
- NCT number
- NCT06390163
What you commit to
- Study type: Interventional
- Participants enrolled: 40
- From 5 May 2024 to the primary completion date, 20 Oct 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Long-term corticosteroid use
Other illness
- Presence of other neurological diseases
- Presence of vision problems (that cannot be compensated with the correct lens) or vestibular disorders that may affect balance, other than symptoms related to Parkinson's disease.
- Serious comorbidities that affect balance and gait or cannot be controlled with life-threatening medication (Diabetes, Hypertension, Cardiopulmonary diseases)
- Presence of orthopedic and systemic diseases that may affect participation in exercise
Who the study is looking for
- Being diagnosed with idiopathic Parkinson's disease
- Being between the ages of 45-75
- Being between stage 2-3 according to the Modified Hoehn-Yahr Staging Scale
- Having a score \> 21 on the Montreal Cognitive Assessment Scale
- Being literate in Turkish
- No drug or dose changes throughout the study.
- Not having participated in any physiotherapy or rehabilitation program in the last 6 months.
- Volunteering to participate in the study
Age in the registry: 45 years to 75 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Hacettepe University Coordinator of this site? Confirm its status | Ankara | Turkey (Türkiye) | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.